Development of Tumor-Induced Osteomalacia in a Subcutaneous Tumor, Defined by Venous Blood Sampling of Fibroblast Growth Factor-23

Internal Medicine - Japan
doi 10.2169/internalmedicine.47.0761
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt

Journal of Investigative Medicine High Impact Case Reports
RiskEpidemiologyReliabilitySafetySafety ResearchQuality
2019English

Tumor-Induced Osteomalacia

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2011English

Effective Localization in Tumor-Induced Osteomalacia Using 68Ga-Dotatoc-Pet/Ct, Venous Sampling and 3t-Mri

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Tumor-Induced Osteomalacia; A Case Report.

Orthopedics & Traumatology
1995English

The Promotion of Plasmacytoma Tumor Growth by Mesenchymal Stroma Is Antagonized by Basic Fibroblast Growth Factor Induced Activin A

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to Extracellular Matrix Degradation

Cancer Research
Cancer ResearchOncology
2010English

Fibroblast Growth Factor 23 Weakens Chemotaxis of Human Blood Neutrophils in Microfluidic Devices

Scientific Reports
Multidisciplinary
2017English

Nonremission and Recurrent Tumor‐induced Osteomalacia: A Retrospective Study

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Multiple Faces of Fibroblast Growth Factor-23

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy